Chap 9
5 Pharmas Spending the Most to Develop Drugs
2012 - Jp Morgan China Conference
Electronic Compliance Monitoring
Janet Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration Todays Biomedical Innovation: Lost in Translation? QB3.
The Statistical Consensus of Non-Inferiority Clinical Trail for NDA in CHINA XIA J.L., PhD. Prof of Biostatistics of FMMU On behalf of CCTS Working Group.
Who Owns the Animals? Kathryn Bayne, M.S., Ph.D., D.V.M., DACLAM Senior Director & Director of Pacific Rim Activities AAALAC International.
Roche Molecular Medicine Laboratories Biomarkers in Personalized Health Care: Opportunities, Challenges, Approaches Klaus Lindpaintner Roche Molecular.
Barriers to Participation in Clinical Trials Pediatric Oncology.
Global Medical Cures™ | Novel New Drugs- 2013 Summary CDER FDA
Pjk abuse liability screening 02 aug-12
Annual Results 2011
